A novel therapeutic combination for neuroblastoma: The vascular endothelial growth factor receptor/epidermal growth factor receptor/rearranged during transfection inhibitor vandetanib with 13-cis-retinoic acid

Peter E. Zage, Lizhi Zeng, Shana Palla, Wendy Fang, Monique B. Nilsson, John V. Heymach, Patrick A. Zweidler-McKay

Research output: Contribution to journalArticlepeer-review

20 Scopus citations

Fingerprint

Dive into the research topics of 'A novel therapeutic combination for neuroblastoma: The vascular endothelial growth factor receptor/epidermal growth factor receptor/rearranged during transfection inhibitor vandetanib with 13-cis-retinoic acid'. Together they form a unique fingerprint.

Medicine & Life Sciences